. . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . . . "V\u00FDvoj koagula\u010Dn\u00EDch marker\u016F chronick\u00E9 diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace (DIK) u pacienta s mnoho\u010Detnou angiomat\u00F3zou v pr\u016Fb\u011Bhu l\u00E9\u010Dby antiangiogenn\u00EDmi l\u00E9ky: interferonem \u03B1, thalidomidem a lenalidomidem" . "CZ - \u010Cesk\u00E1 republika" . "Thalidomide 100 mg/day stabilized multiple angiomatosis better than interferon alfa. Thalidomide 50 mg/day was insufficient to maintain disease stability. Lenalidomide at a dose of 10 mg was tolerated really well but this dose was insufficient to maintain low D-dimer levels and normal haemoglobin concentrations. The combination of lenalidomide 10 mg and thalidomide 50 mg daily stabilized the disease for 9 months."@en . . . "Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with antiangiogenics: interferon \u03B1, thalidomide and lenalidomide"@en . "V\u00FDvoj koagula\u010Dn\u00EDch marker\u016F chronick\u00E9 diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace (DIK) u pacienta s mnoho\u010Detnou angiomat\u00F3zou v pr\u016Fb\u011Bhu l\u00E9\u010Dby antiangiogenn\u00EDmi l\u00E9ky: interferonem \u03B1, thalidomidem a lenalidomidem" . . . . "http://www.prolekare.cz/vnitrni-lekarstvi-clanek/vyvoj-koagulacnich-markeru-chronicke-diseminovane-intravaskularni-koagulace-dik-u-pacienta-s-mnohocetnou-37440" . . "[406D43F31F57]" . "Thalidomid 100 mg/den stabilizoval mnoho\u010Detnou angiomat\u00F3zu l\u00E9pe ne\u017E interferon alfa. Thalidomid 50 mg/den ji\u017E neudr\u017Eel stabilitu nemoci. Lenalidomid v d\u00E1vce 10 mg byl excelentn\u011B tolerov\u00E1n, ale tato d\u00E1vka nedosta\u010Dovala pro udr\u017Een\u00ED stabiln\u011B n\u00EDzk\u00FDch hodnot D-dimer\u016F a norm\u00E1ln\u00ED koncentrace hemoglobinu. Kombinace 10 mg lenalidomidu a 50 mg thalidomidu denn\u011B stabilizovala nemoc na dlouh\u00FDch 9 m\u011Bs\u00EDc\u016F." . "RIV/00209805:_____/12:#0000388" . . "Thalidomid 100 mg/den stabilizoval mnoho\u010Detnou angiomat\u00F3zu l\u00E9pe ne\u017E interferon alfa. Thalidomid 50 mg/den ji\u017E neudr\u017Eel stabilitu nemoci. Lenalidomid v d\u00E1vce 10 mg byl excelentn\u011B tolerov\u00E1n, ale tato d\u00E1vka nedosta\u010Dovala pro udr\u017Een\u00ED stabiln\u011B n\u00EDzk\u00FDch hodnot D-dimer\u016F a norm\u00E1ln\u00ED koncentrace hemoglobinu. Kombinace 10 mg lenalidomidu a 50 mg thalidomidu denn\u011B stabilizovala nemoc na dlouh\u00FDch 9 m\u011Bs\u00EDc\u016F."@cs . "2" . . . "9"^^ . . "Adam, Zden\u011Bk" . . . "RIV/00209805:_____/12:#0000388!RIV13-MZ0-00209805" . . . "lenalidomide; thalidomide; hemangiomatosis; angiomatosis; D-dimers; chronic disseminated intravascular coagulation; PET-CT imaging"@en . . . "Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with antiangiogenics: interferon \u03B1, thalidomide and lenalidomide"@en . . "\u0158eh\u00E1k, Zden\u011Bk" . "58" . . "2"^^ . "Koukalov\u00E1, Renata" . . . "P(LC06027), P(NT11154), P(NT12130), P(NT12215), Z(MZ0MOU2005)" . . "V\u00FDvoj koagula\u010Dn\u00EDch marker\u016F chronick\u00E9 diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace (DIK) u pacienta s mnoho\u010Detnou angiomat\u00F3zou v pr\u016Fb\u011Bhu l\u00E9\u010Dby antiangiogenn\u00EDmi l\u00E9ky: interferonem \u03B1, thalidomidem a lenalidomidem"@cs . "15"^^ . "V\u00FDvoj koagula\u010Dn\u00EDch marker\u016F chronick\u00E9 diseminovan\u00E9 intravaskul\u00E1rn\u00ED koagulace (DIK) u pacienta s mnoho\u010Detnou angiomat\u00F3zou v pr\u016Fb\u011Bhu l\u00E9\u010Dby antiangiogenn\u00EDmi l\u00E9ky: interferonem \u03B1, thalidomidem a lenalidomidem"@cs . "0042-773X" . . "179856" .